Tuesday, March 18, 2025 | 07:02 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India Coronavirus Dispatch: Glaring gaps at local level caused recent spike

UP adds drug without evidence, govt to seek $2.5 mn aid from ADB, and the role of communication in controlling Covid--news on how the country is dealing with the pandemic

Photo: Shutterstock
Premium

Photo: Shutterstock

Shreegireesh Jalihal New Delhi
UP adds drug without evidence: Uttar Pradesh has added ivermectin, an anti-parasitic drug, as a treatment and prophylaxis against coronavirus. The alarming fact is that the use of this drug against Covid-19 has no scientific basis yet. In fact, experts from the WHO have actually warned against using ivermectin. Similarly, the US FDA hasn’t approved it either and neither has India’s Health Ministry. UP state govt hospitals and rapid response teams, however, have been tasked with distributing the drug to those under quarantine. Experts who have studied the drug over years also advice against its usage in battling the pandemic.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in